Exploring the declining trends in HIV drug resistance and the scientific advances driving this positive change in modern antiretroviral therapy.
Exploring the evidence behind two-drug HIV regimens in Africa, their advantages, clinical trial results, and future implications for HIV care across the continent.
Discover how different antiretroviral regimens affect viral suppression and immune activation during early HIV treatment.
Discover how treatment adherence impacts the efficacy of modern HIV regimens like DTG/3TC and DTG + TDF/FTC based on the GEMINI clinical trials analysis.
Exploring the effectiveness of pediatric antiretroviral therapy in resource-limited settings through systematic review and meta-analysis.
Explore the research trends in HIV-1 capsid inhibitors from 2000-2022, including structural insights, clinical developments, and future therapeutic directions.
Comprehensive analysis of third-line antiretroviral therapy outcomes for HIV patients, including global success rates and factors influencing treatment effectiveness.
Explore the comparison of antiretroviral therapy regimens for treatment-naive HIV-positive patients, focusing on virological response, immunological response, and adverse effects.
Exploring whether simpler two-drug HIV regimens can control chronic inflammation as effectively as traditional three-drug therapies.
Explore how long-acting injectable HIV therapy is transforming treatment with real-world evidence from the OPERA cohort showing sustained viral suppression and improved quality of life.